Evidence map›Paper›PMID 9199285›Full record

ArticleMolecular and cellular biology1997

Transactivation domains facilitate promoter occupancy for the dioxin-inducible CYP1A1 gene in vivo.

H P Ko, S T Okino, Q Ma, J P Whitlock

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. The mouse and human Ah receptor differ in recognition of LXXLL motifs.Archives of biochemistry and biophysics · 2008
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

H P KoDepartment of Molecular Pharmacology, Stanford University School of Medicine, California 94306-5332, USA.
S T Okino
Q Ma
J P Whitlock
Stanford University · US

Funding

MECHANISM OF DIOXIN ACTIONR01CA053887 · NCI · STANFORD UNIVERSITY · PI WHITLOCK, JAMES P · 1998 to 2001
$537k
MECHANISM OF DIOXIN ACTIONR35CA053887 · NCI · STANFORD UNIVERSITY · PI WHITLOCK, JAMES P · 1991 to 1997
–
NCI NIH HHS CA53887
6 · The paper itself

Abstract

We have studied the transcriptional regulation of the dioxin-inducible mouse CYP1A1 gene in its native chromosomal setting. We analyzed the ability of aromatic hydrocarbon receptor (AhR) mutants and AhR chimeras to restore dioxin responsiveness to the CYP1A1 gene in AhR-defective mouse hepatoma cells. Our data reveal that transactivation domains in AhR's C-terminal half mediate occupancy of the nuclear factor 1 site and TATA box for the CYP1A1 promoter in vivo. Transactivation domains of VP16 and AhR nuclear translocator, but not Sp1, can substitute for AhR's C-terminal half in facilitating protein binding at the promoter. Our data also reveal an apparent linear relationship between promoter occupancy and CYP1A1 gene expression in chromatin. These findings provide new insights into the in vivo mechanism of transcriptional activation for an interesting mammalian gene.

Indexed as

AnimalsAryl Hydrocarbon Receptor Nuclear TranslocatorCytochrome P-450 CYP1A1DioxinsDNA-Binding ProteinsEnhancer Elements, GeneticGene Expression Regulation, EnzymologicMicePromoter Regions, GeneticReceptors, Aryl HydrocarbonRecombinant Fusion ProteinsTranscriptional ActivationTranscription FactorsArnt protein, mouseAryl Hydrocarbon Receptor Nuclear TranslocatorCytochrome P-450 CYP1A1DioxinsDNA-Binding ProteinsReceptors, Aryl HydrocarbonRecombinant Fusion ProteinsTranscription Factors

Identifiers

PMID9199285
PMCPMC232203
OpenAlexW1884481283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.